SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

 

STARTUP NEWS

WUXI NEWS

Historic Approvals Highlighted at the Second China Innovative Drug Ecosystem Forum 2018

The recent China Innovative Drug Ecosystem Forum, organized by STA Pharmaceutical, a WuXi AppTec company (WuXi STA), was a resounding success with apt timing following the recent announcements of  history-making new...

New Therapies Targeting Causes of Parkinson’s Disease Generate Optimism for a Cure

While Parkinson’s disease was first characterized 200 years ago, significant progress in unraveling the causes of the neurodegenerative syndrome has occurred only this century. This has accelerated drug development to the...

Role Model: Merging Academic Science with Industry to Accelerate Drug Discovery

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) Over the last several years, the translation of academic research into new drugs has become a much riskier and challenging process....

A Futuristic Biopharma Company Addressing Some of the World’s Biggest Health Problems

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) For the past few years, PureTech Health has been building a new R&D model for advancing breakthrough scientific discoveries to help solve some of...

WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock...

We are pleased to announce WuXi AppTec's  listing of Initial Public Offering of common stock on the Shanghai Stock Exchange. Proceeds from the IPO will be used to build and expand...

FDA UPDATES